Autosomal dominant polycystic kidney disease

Area of Science:

• Nephrology
• Genetics
• Internal Medicine

Background:

• Autosomal dominant polycystic kidney disease (ADPKD) is a prevalent inherited condition in the U.S.
• Affects approximately 500,000 Americans, contributing 5-10% of end-stage renal disease cases.
• Typically diagnosed in middle age with complications like hypertension, pain, and hematuria.

Purpose of the Study:

• To summarize the key aspects of autosomal dominant polycystic kidney disease.
• To outline common renal and extra-renal manifestations.
• To discuss current management strategies and treatment outcomes.

Main Methods:

• Literature review of autosomal dominant polycystic kidney disease.
• Analysis of disease prevalence and impact on end-stage renal disease.
• Summary of clinical presentation, complications, and management.

Main Results:

• ADPKD presents with renal complications (hypertension, cyst infection, hematuria) and other conditions (polycystic liver disease, cerebral aneurysms).
• Disease course and severity exhibit significant inter-individual variability.
• Effective management includes hypertension control, complication treatment, and supportive therapies.

Conclusions:

• ADPKD requires comprehensive management addressing both renal and systemic complications.
• Genetic counseling is crucial for affected families.
• Dialysis and renal transplantation are effective for end-stage renal disease secondary to ADPKD.